治療性H7N9 禽流感病毒人源中和抗體之製作與驗證
陳宜萾 - 2015 - tdr.lib.ntu.edu.tw
… have been reported to elicit the broadly neutralizing antibodies and provide cross protection
… broadly neutralizing Abs, it is of great importance to develop novel strategies to advance the …
… broadly neutralizing Abs, it is of great importance to develop novel strategies to advance the …
合成生物技术助力纳米颗粒疫苗理性设计时代的到来
马雪璟， 郭畅， 华兆琳， 侯百东 - 合成生物学, 2024 - synbioj.cip.com.cn
… , requiring groundbreaking advancement in novel technologies … Furthermore, discoveries
in understanding the unique roles of … Vaccination induces HIV broadly neutralizing antibody …
in understanding the unique roles of … Vaccination induces HIV broadly neutralizing antibody …
免疫菌的抗病毒作用与抗新型冠状病毒肺炎应用潜力
陈雨露， 卢思敏， 罗文博， 曹治杰， 杨晶， 任志鸿… - 疾病监测, 2022 - jbjc.org
… and maintenance of SARS-CoV-2 neutralization antibodies in mice even 6 months after …
of SARS-COV-2 specific neutralizing antibody in bronchoalveolar lavage increased by 8 …
of SARS-COV-2 specific neutralizing antibody in bronchoalveolar lavage increased by 8 …
[PDF][PDF] 圓Plenary Lecture (PL)
R Huber - ksabc.or.kr
… extending our discoveries of how flavor/fragrance plant chemicals, such as eugenol/isoeugenol
are formed, and their potential role as new commodity chemicals; our discoveries and …
are formed, and their potential role as new commodity chemicals; our discoveries and …
[HTML][HTML] mRNA 技术应对病毒传染病的研究进展
田颖， 张娜娜， 秦成峰， 李晓峰 - 微生物学通报, 2022 - wswxtb.ijournals.cn
: 信使核糖核酸(messenger RNA, mRNA) 疫苗和抗体是近年来兴起的一种新型疫苗和抗体技术
. 与传统疫苗相比, mRNA 疫苗具有安全性高, 均衡免疫性好, 研发周期短, 生产成本低等优势, …
. 与传统疫苗相比, mRNA 疫苗具有安全性高, 均衡免疫性好, 研发周期短, 生产成本低等优势, …
病毒载体疫苗研究进展
王步森， 徐婧含， 高智强， 侯利华 - 合成生物学, 2024 - synbioj.cip.com.cn
… A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and
protective neutralizing antibodies against SARS-CoV-2[J]. PLoS Pathogens, 2021, 17(12): …
protective neutralizing antibodies against SARS-CoV-2[J]. PLoS Pathogens, 2021, 17(12): …
[HTML][HTML] 基孔肯雅病毒抑制剂研究进展
姜向毅， 李敬， 魏晓颖， 展鹏， 刘新泳 - 药学学报, 2020 - html.rhhz.net
… classical inhibitors of CHIKV, and summarized the medicinal chemistry strategies for discovering
CHIKV inhibitors. … Figure 4 The discovery of 3 via structural optimization of arbidol (2) …
CHIKV inhibitors. … Figure 4 The discovery of 3 via structural optimization of arbidol (2) …
合成生物学在感染性疾病防治中的应用
蒲璐， 黄亚佳， 杨帅， 金帆 - 合成生物学, 2020 - synbioj.cip.com.cn
… 通常情况下,HIV病毒主要通过CCR5基因编 码白细胞上的一种受体进入细胞.如果个体携带 两
个CCR5突变拷贝,那么HIV病毒株无法进入细 胞.但这种抗HIV基因特别罕见:仅1%的欧洲血 统…
个CCR5突变拷贝,那么HIV病毒株无法进入细 胞.但这种抗HIV基因特别罕见:仅1%的欧洲血 统…
[图书][B] 医学论文英文摘要写作手册
王全楚， 马可为 - 2004 - books.google.com
… The overall operative morbidity was 54 percent, and the hospital mortality was 11 percent.
Significant factors contributing to this high rate of complications included a delay in diagnosis, …
Significant factors contributing to this high rate of complications included a delay in diagnosis, …
停經後骨質疏鬆婦女運動訓練計畫之效果與成本評估
李瑋君 - 2011 - tdr.lib.ntu.edu.tw
… It also affects bone loss and bone health in advanced age … In addition to these vital calcemic
actions, the discovery of the nuclear receptor of 1,25(OH)2D3 opened the possibility that …
actions, the discovery of the nuclear receptor of 1,25(OH)2D3 opened the possibility that …